-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Outcomes and Economic Impact of Treatment with CABLIVI (caplacizumab-yhdp)

Sponsor: Sanofi
Program: Product Theaters
Monday, December 11, 2023: 12:15 PM-1:15 PM
Room 4 (San Diego Convention Center)
Rahul Bohra, MSc, PhD, Sanofi and Alix Arnaud, MSc, Sanofi
No relevant conflicts of interest to declare.
For In-Person Participants Only
See more of: Product Theaters